Patents Assigned to JIANGZHONG PHARMACEUTICAL CO., LTD.
  • Patent number: 10537600
    Abstract: The present invention relates to a traditional Chinese medicine composition for regulating immunity and preparation method thereof, characterized in that the composition comprises raw materials such as Radix Panacis Quinquefolii, Ganoderma, fermented Cordyceps sinensis powder, Flos Rosae Rugosae, and Rhizoma Anemarrhenae and is prepared into various conventional pharmaceutical formulations through processes such as pulverization, water decoction and alcohol extraction. The traditional Chinese medicine composition is effective in preventing and treating allergic diseases, hepatitis B and AIDS, elevating leukocytes, preventing and treating radiation injury, reducing toxic and side effects resulting from radiotherapy and chemotherapy, improving the male sexual function, enhancing immunity of the human body and alleviating physical fatigue.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: January 21, 2020
    Assignee: JIANGZHONG PHARMACEUTICALS CO., LTD.
    Inventors: Hongguang Zhong, Minzhi Yi, Jianzhong Lu
  • Patent number: 10391133
    Abstract: The present invention relates to a traditional Chinese medicine composition for regulating immunity and preparation method thereof, characterized in that the composition comprises raw materials such as Radix Panacis Quinquefolii, Ganoderma, fermented Cordyceps sinensis powder, Flos Rosae Rugosae, and Rhizoma Anemarrhenae and is prepared into various conventional pharmaceutical formulations through processes such as pulverization, water decoction and alcohol extraction. The traditional Chinese medicine composition is effective in preventing and treating allergic diseases, hepatitis B and AIDS, elevating leukocytes, preventing and treating radiation injury, reducing toxic and side effects resulting from radiotherapy and chemotherapy, improving the male sexual function, enhancing immunity of the human body and alleviating physical fatigue.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: August 27, 2019
    Assignee: JIANGZHONG PHARMACEUTICALS CO., LTD.
    Inventors: Hongguang Zhong, Minzhi Yi, Jianzhong Lu
  • Patent number: 10086030
    Abstract: The present invention relates to use of a composition in the manufacture of health care products or medicaments for prevention and treatment of allergic diseases. The composition is made from raw materials comprising 5 to 200 parts by weight of Ganoderma, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented Cordyceps sinensis powder and/or 1 to 120 parts by weight of Cordyceps, or is a composition made from water and/or alcohol extracts of the above raw materials as active components. The allergic diseases include allergic rhinitis, allergic dermatitis, urticaria, and/or allergic asthma.
    Type: Grant
    Filed: May 27, 2013
    Date of Patent: October 2, 2018
    Assignee: Jiangzhong Pharmaceutical Co., Ltd.
    Inventors: Hongguang Zhong, Minzhi Yi, Jianzhong Lu
  • Patent number: 9775868
    Abstract: The present invention relates to a traditional Chinese medicine composition for regulating immunity and preparation method thereof, characterized in that the composition comprises raw materials such as Radix Panacis Quinquefolii, Ganoderma, fermented Cordyceps sinensis powder, Flos Rosae Rugosae, and Rhizoma Anemarrhenae and is prepared into various conventional pharmaceutical formulations through processes such as pulverization, water decoction and alcohol extraction. The traditional Chinese medicine composition is effective in preventing and treating allergic diseases, hepatitis B and AIDS, elevating leukocytes, preventing and treating radiation injury, reducing toxic and side effects resulting from radiotherapy and chemotherapy, improving the male sexual function, enhancing immunity of the human body and alleviating physical fatigue.
    Type: Grant
    Filed: September 22, 2013
    Date of Patent: October 3, 2017
    Assignee: JIANGZHONG PHARMACEUTICAL CO., LTD.
    Inventors: Hongguang Zhong, Minzhi Yi, Jianzhong Lu
  • Patent number: 9744203
    Abstract: The present invention relates to use of a composition in the manufacture of a health care product or medicament for preventing and treating leucopenia induced by radiotherapy or chemotherapy. The composition is made from raw materials comprising 5 to 200 parts by weight of Ganoderma, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented Cordyceps sinensis powder and/or 1 to 120 parts by weight of Cordyceps, or is a composition consisting of water and/or alcohol extracts of the above raw materials as active components.
    Type: Grant
    Filed: May 27, 2013
    Date of Patent: August 29, 2017
    Assignee: JIANGZHONG PHARMACEUTICAL CO., LTD.
    Inventors: Hongguang Zhong, Minzhi Yi, Jianzhong Lu
  • Publication number: 20150290275
    Abstract: The present invention relates to use of a composition in the manufacture of a health care product or medicament for preventing and treating leucopenia induced by radiotherapy or chemotherapy. The composition is made from raw materials comprising 5 to 200 parts by weight of Ganoderma, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented Cordyceps sinensis powder and/or 1 to 120 parts by weight of Cordyceps, or is a composition consisting of water and/or alcohol extracts of the above raw materials as active components.
    Type: Application
    Filed: May 27, 2013
    Publication date: October 15, 2015
    Applicant: JIANGZHONG PHARMACEUTICAL CO., LTD.
    Inventors: Hongguang Zhong, Minzhi Yi, Jianzhong Lu
  • Patent number: 8986750
    Abstract: The present invention provides a use of traditional Chinese medicine composition for manufacturing a health food or medicament for preventing and alleviating physical fatigue. The composition consists of 5-90 parts by weight of Radix Panacis Quinquefolii, 5-160 parts by weight of Ganoderma, 1-90 parts by weight of fermented Cordyceps sinensis powder and/or 1-120 parts by weight of Cordyceps, and these ingredients are made from Chinese crude drugs or from Chinese crude drug extracts in amounts equivalent to those of the Chinese crude drugs. The composition may further contain 5-90 parts by weight of Flos Rosae Rugosae. The present invention also relates to the use of said composition in the manufacture of prophylactic or therapeutic health foods or medicaments for reducing blood lipids, for resisting oxidation, and for enhancing anoxia endurance. The medicine composition of the present invention can be prepared into any conventional dosage forms by adding any pharmaceutically acceptable auxiliary agents.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: March 24, 2015
    Assignee: Jiangzhong Pharmaceutical Co., Ltd.
    Inventors: Hongguang Zhong, Minzhi Yi, Jianzhong Lu, Yiguang Li, Li Ma, Yongjin Guo, Jinzhen Xu, Yibin Lv, Meixiang Yao
  • Publication number: 20130243748
    Abstract: The present invention provides a use of traditional Chinese medicine composition for manufacturing a health food or medicament for preventing and alleviating physical fatigue. The composition consists of 5-90 parts by weight of Radix Panacis Quinquefolii, 5-160 parts by weight of Ganoderma, 1-90 parts by weight of fermented Cordyceps sinensis powder and/or 1-120 parts by weight of Cordyceps, and these ingredients are made from Chinese crude drugs or from Chinese crude drug extracts in amounts equivalent to those of the Chinese crude drugs. The composition may further contain 5-90 parts by weight of Flos Rosae Rugosae. The present invention also relates to the use of said composition in the manufacture of prophylactic or therapeutic health foods or medicaments for reducing blood lipids, for resisting oxidation, and for enhancing anoxia endurance. The medicine composition of the present invention can be prepared into any conventional dosage forms by adding any pharmaceutically acceptable auxiliary agents.
    Type: Application
    Filed: September 16, 2011
    Publication date: September 19, 2013
    Applicant: JIANGZHONG PHARMACEUTICAL CO., LTD.
    Inventors: Hongguang Zhong, Minzhi Yi, Jianzhong Lu, Yiguang Li, Li Ma, Yongjin Guo, Jinzhen Xu, Yibin Lv, Meixiang Yao